China’s CanSino defends coronavirus vaccine candidate after experts cast doubt

China’s CanSino Biologics Inc 6185.HK, 688185.SS said on Wednesday expert opinion on its high-profile coronavirus vaccine candidate should not be followed “blindly” without sufficient clinical trial …
( read original story …)